A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
- Conditions
- HIV Infections
- Registration Number
- NCT00002227
- Lead Sponsor
- Dupont Merck
- Brief Summary
The purpose of this study is to see if it is safe and effective to give efavirenz plus stavudine plus lamivudine to patients who have never taken anti-HIV drugs.
- Detailed Description
Patients will be given combination treatment with efavirenz, stavudine, and lamivudine.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 60
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Richard Elion
🇺🇸Washington, District of Columbia, United States
The Whitman Walker Clinic
🇺🇸Washington, District of Columbia, United States
Community Research Initiative of New England
🇺🇸Brookline, Massachusetts, United States
Remington Davis Inc
🇺🇸Columbus, Ohio, United States
The Milton S Hersey Med Ctr / Div of Hematology
🇺🇸Hershey, Pennsylvania, United States
Coastal Carolina Research Ctr
🇺🇸Mount Pleasant, South Carolina, United States
Montrose Clinic
🇺🇸Houston, Texas, United States
Hampton Roads Med Specialists
🇺🇸Hampton, Virginia, United States
Richard Elion🇺🇸Washington, District of Columbia, United States